{"id":120129,"date":"2021-04-07T07:14:20","date_gmt":"2021-04-07T07:14:20","guid":{"rendered":"https:\/\/precoinnews.com\/?p=120129"},"modified":"2021-04-07T07:14:20","modified_gmt":"2021-04-07T07:14:20","slug":"factbox-some-countries-limit-astrazeneca-vaccine-use-amid-concern-over-blood-clots","status":"publish","type":"post","link":"https:\/\/precoinnews.com\/markets\/factbox-some-countries-limit-astrazeneca-vaccine-use-amid-concern-over-blood-clots\/","title":{"rendered":"Factbox: Some countries limit AstraZeneca vaccine use amid concern over blood clots"},"content":{"rendered":"
(Reuters) – Some countries are restricting use of the AstraZeneca vaccine against COVID-19 while others have resumed inoculations, as investigations into reports of rare, and sometimes severe, blood clots continue.<\/p> The European Medicines Agency and the World Health Organization have said the benefits outweigh the risks, but are monitoring the situation.<\/p>\n AstraZeneca said in March its vaccine was 76% effective in preventing symptomatic infections in a U.S. trial, and that studies did not indicate higher risks of clotting.<\/p>\n Will continue its inoculation programme with the shot despite a blood clotting case reported on April 2, health officials said on April 3.<\/p>\n Resumed use.<\/p>\n Resumed inoculations from March 19.<\/p>\n Cyprus resumed inoculations on March 19.<\/p>\n To pause offering vaccine to people aged under 55 and require a new analysis of the shot\u2019s benefits and risks based on age and gender.<\/p>\n Approved resumed use of the vaccine on March 19, but said it should only be given to people aged 55 and over.<\/p>\n Resumed using the AstraZeneca vaccine from March 29, but will only give it to people aged 65 and over.<\/p>\n Has limited the use of the vaccine after a nurse died of anaphylactic shock, and vaccinations will continue only in full-fledged medical centres, news agency TASS reported on March 19.<\/p>\n From March 31, Germany limited use of the shot to people over 60 and high-priority groups, following further reports of a rare brain blood disorder. On April 1, Germany\u2019s vaccine commission recommended that people under 60 who have had a first shot of AstraZeneca\u2019s vaccine should receive a different product for their second dose.<\/p>\n Resumed use on March 25 after suspending it on March 11.<\/p>\n Resumed using the vaccine on March 22 but warned against the use of the vaccine in people with a low blood platelet count.<\/p>\n Resumed use after EMA recommendation.<\/p>\n Resumed use on March 19, and Italians who decline to be inoculated with it will be given an alternative later.<\/p>\n Said would restart administering the shots from March 19.<\/p>\n Restarted use on March 19, currently for over 65-year-olds only.<\/p>\n Currently using the vaccine only for over 60s, either at a doctors\u2019 surgery or by a doctor at nursing homes.<\/p>\n Health Minister Venko Filipce said on March 31 that AstraZeneca shots would be limited to people aged over 60 as a precautionary measure.<\/p>\n Resumed use after the EMA assessment after temporarily stopping vaccinating people with one batch of the vaccine on March 11.<\/p>\n President Moon Jae-in received the vaccine on March 23 ahead of an overseas trip, as the country inoculates senior citizens and health workers.<\/p>\n Spain said on March 30 it would use the vaccine for people aged 55-65, and a day later said it would extend the vaccination to essential workers aged over 65.<\/p>\n Resumed use of the vaccine on March 25 for people aged 65 and older, but restrictions are in place for Swedes under 65.<\/p>\n Began use on March 15, with Prime Minister Prayuth Chan-ocha the first to be inoculated, after delaying rollout the week before.<\/p>\n Suspended administration of the vaccine it was scheduled to receive on March 20 as part of the global vaccines sharing scheme COVAX, the health ministry said.<\/p>\n Will prolong its suspension of the shot by three weeks pending further investigations after its two-week pause ended on March 25. A local survey indicated that one in three Danes would decline to get the shot.<\/p>\n Norway will delay a decision over the use of the vaccine, authorities said on March 26, with a decision expected by April 15.<\/p>\nVACCINE BEING USED, WITH OR WITHOUT RESTRCTIONS<\/h2>\n
AUSTRALIA:<\/h2>\n
AUSTRIA:<\/h2>\n
BULGARIA:<\/h2>\n
CYPRUS:<\/h2>\n
CANADA:<\/h2>\n
FRANCE:<\/h2>\n
FINLAND:<\/h2>\n
GEORGIA:<\/h2>\n
GERMANY:<\/h2>\n
ICELAND:<\/h2>\n
INDONESIA:<\/h2>\n
IRELAND:<\/h2>\n
ITALY:<\/h2>\n
LATVIA:<\/h2>\n
LITHUANIA:<\/h2>\n
NETHERLANDS:<\/h2>\n
NORTH MACEDONIA:<\/h2>\n
ROMANIA:<\/h2>\n
SOUTH KOREA:<\/h2>\n
SPAIN:<\/h2>\n
SWEDEN:<\/h2>\n
THAILAND:<\/h2>\n
USE SUSPENDED<\/h2>\n
CAMEROON:<\/h2>\n
DENMARK:<\/h2>\n
NORWAY:<\/h2>\n